Longboard Pharmaceuticals...

AI Score

0

Unlock

59.98
0.00 (0.00%)
At close: Nov 29, 2024, 6:00 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue n/a n/a n/a n/a
Cost of Revenue 5.00K 5.00K 1K n/a
Gross Profit -5.00K -5.00K -1K n/a
Operating Income -56.76M -44.80M -27.84M -14.40M
Interest Income 2.40M 837.00K 64.00K n/a
Pretax Income -54.42M -43.95M -27.80M -14.40M
Net Income -54.42M -43.09M -27.73M -14.40M
Selling & General & Admin 13.01M 10.16M 8.06M 9.77M
Research & Development 43.75M 34.64M 19.77M 4.63M
Other Expenses n/a 16.00K -22.00K n/a
Operating Expenses 56.76M 44.80M 27.84M 14.40M
Interest Expense n/a 837.00K n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 56.76M 44.80M 27.84M 14.40M
Income Tax n/a -853.00K -64.00K -14.40K
Shares Outstanding (Basic) 22.73M 17.15M 17.07M 17.67M
Shares Outstanding (Diluted) 22.73M 17.15M 17.07M 17.67M
EPS (Basic) -2.39 -2.51 -1.62 -0.82
EPS (Diluted) -2.39 -2.51 -1.62 -0.82
EBITDA -56.75M -44.79M -27.84M -14.40M
Depreciation & Amortization 5.00K 5.00K 1K 7.00M